Quarterly report pursuant to sections 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.6
Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended 63 Months Ended
Apr. 30, 2013
Apr. 30, 2012
Apr. 30, 2013
Apr. 30, 2012
Apr. 30, 2013
Consolidated Statements of Operations          
Revenue $ 0 $ 0 $ 0 $ 0 $ 0
Expenses:          
Research and development 707,660 701,201 2,362,872 1,725,194 5,416,022
General and administrative 1,001,518 887,648 2,941,625 2,238,222 7,179,182
Loss from operations (1,709,178) (1,588,849) (5,304,497) (3,963,416) (12,595,204)
Other income (expense):          
Fair value of derivative liabilities in excess of proceeds         (808,590)
Adjustments to fair value of derivative liabilities   1,613,329   4,192,781 3,150,985
Loss on extinguishment of debt   (761,492)   (761,492) (761,492)
Financing transaction costs         (210,000)
Non-cash interest expense (19,481) (74,562) (71,075) (236,864) (337,642)
Interest expense         (1,357)
Impairment charges 0   0   (9,000)
Net income (loss) before income taxes (1,728,659) (811,574) (5,375,572) (768,991) (11,572,300)
Provision for income taxes     2,000 2,400 6,000
Net income (loss) $ (1,728,659) $ (811,574) $ (5,377,572) $ (771,391) $ (11,578,300)
Basic net income (loss) per common share (in dollars per share) $ (0.01) $ (0.01) $ (0.05) $ (0.01)  
Diluted net income (loss) per common share (in dollars per share) $ (0.01) $ (0.01) $ (0.05) $ (0.01)  
Weighted average shares used in computing basic net income (loss) per common share (in shares) 117,859,000 68,222,667 102,717,806 60,589,577  
Weighted average shares used in computing diluted net income (loss) per common share (in shares) 117,859,000 68,222,667 102,717,806 60,589,577